10 Years of Liquid Biopsy: Igniting a New Era in Precision Oncology
- Highlighting key scientific, technological, and regulatory milestones that have shaped the past decade of liquid biopsy innovation
- Identifying the most pressing challenges that still hinder broader adoption across trial phases, tumor types, and clinical settings
- Outlining the next strategic priorities needed to ensure liquid biopsies become a standard, validated tool for patient selection, monitoring, and treatment optimization in every clinical trial